Combination Therapy With Exenatide Plus Pioglitazone Versus Basal/Bolus Insulin in Patients With Poorly Controlled Type 2 Diabetes on Sulfonylurea Plus Metformin: The Qatar Study

Những quyển sách tương tự

• Erratum. Combination Therapy With Exenatide Plus Pioglitazone Versus Basal/Bolus Insulin in Patients With Poorly Controlled Type 2 Diabetes on Sulfonylurea Plus Metformin: The Qatar Study. Diabetes Care 2017;40:325–331
  Bằng: Abdul-Ghani, Muhammad, et al.
  Được phát hành: (2017)
• Effect of treatment with exenatide and pioglitazone or basal-bolus insulin on diabetic neuropathy: a substudy of the Qatar Study
  Bằng: Ponirakis, Georgios, et al.
  Được phát hành: (2020)
• Effects of Exenatide Plus Rosiglitazone on β-Cell Function and Insulin Sensitivity in Subjects With Type 2 Diabetes on Metformin
  Bằng: DeFronzo, Ralph A., et al.
  Được phát hành: (2010)
• Glycated hemoglobin versus oral glucose tolerance test in the identification of subjects with prediabetes in Qatari population
  Bằng: Iskandar, Saadallah, et al.
  Được phát hành: (2019)
• Initial combination therapy with metformin, pioglitazone and exenatide is more effective than sequential add-on therapy in subjects with new-onset diabetes. Results from the Efficacy and Durability of Initial Combination Therapy for Type 2 Diabetes (EDICT): a randomized trial
  Bằng: Abdul-Ghani, M. A., et al.
  Được phát hành: (2015)